Project Grant HT9425261E035
Award Date 9/30/26
Completion Date 9/29/29
Dollars Obligated $1.7M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
New York, NY 10016, USA
Similar Awards
- Federal Project Grant Award Summary New York University School of Medicine received a $833,334 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective September 30, 2026, with a completion date of September 29, 2029. The award supports a three-year research initiative titled "Identifying Pathways that Prevent the Emergence of Drug-Tolerant Persisters," which investigates mechanisms to prevent the...
- Federal Project Grant Award Summary New York University School of Medicine received a $1.35M Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), awarded June 15, 2026, with completion targeted for June 14, 2029. The project, titled "Neoadjuvant Checkpoint and IL-6 Blockade: Mechanisms of Benefit and Toxicity," supports biomedical research investigating immunotherapy approaches for cancer treatment. The research...
- Federal Project Grant Award Summary New York University received an $818,929 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) on September 30, 2025, with an ultimate completion date of September 29, 2029. The award funds the implementation of a formal postvention program designed to support military mental health clinicians. Postvention services typically focus on intervention and support following critical incidents,...
- Federal Grant Award Summary New York University School of Medicine received a $750,962 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded on June 15, 2026, with a completion date of June 14, 2029. The project, titled "Neoadjuvant Checkpoint and IL-6 Blockade: Mechanisms of Benefit and Toxicity," supports biomedical research investigating immunotherapy approaches and their clinical outcomes. This...
- Federal Grant Award Summary New York University School of Medicine received a $2.01M Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025, through June 30, 2028. The award supports research titled "Targeting RAGE After Particulate Matter Exposure: Metabolic Dysregulation and Disease Mitigation," conducted at NYU's location in New York, New York. This research investigates the...
- Federal Grant Award Summary New York University School of Medicine has received a $680,757 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research titled "Targeting RAGE After Particulate Matter Exposure: Metabolic Dysregulation and Disease Mitigation." The three-year award, effective July 1, 2025 through June 30, 2028, supports biomedical research investigating the mechanisms by which particulate matter...
- Federal Grant Award Summary New York University School of Medicine has received a $2.54 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025 through July 31, 2028. The award supports research and development activities focused on advancing a novel therapeutic strategy for amyotrophic lateral sclerosis (ALS) treatment through investigation of the RAGE/DIAPH1 axis. As a premier academic medical...
- Federal Project Grant Award Summary New York University received a $791,063 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) awarded on September 30, 2025, with an ultimate completion date of September 29, 2029. The award funds the implementation of a formal postvention program designed to serve military mental health clinicians. Postvention—intervention following a suicide or suicide attempt—represents a critical gap in...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Trustees of Columbia University in the City of New York's Health Sciences Division a $1.645 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2025, through June 30, 2028. The award supports research on treating HER2 therapy-resistant brain metastasis using antidepressants, conducted at Columbia's Health Sciences Division facility in New York, NY. This project...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded $352,000 under the Military Medical Research and Development program (CFDA 12.420) to the Sloan-Kettering Institute for Cancer Research for the project period September 1, 2025, through August 31, 2027. The award supports research focused on augmenting the in vivo efficacy of a novel lanosterol synthase inhibitor in glioblastoma treatment. This research aligns with the DHA's mission to transform healthcare for service...